.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Dr. Norm's category mix tilted away from Edible toward Capsules: Edible held 60.22% share with a year-over-year decline of 5.66% and a month-over-month drop of 18.71%, while Capsules expanded to 29.29% share with a 2,281.68% year-over-year surge and a 4.49% month-over-month gain; Vapor Pens accounted for 10.49% share with 8.77% year-over-year and 7.09% month-over-month growth. Despite a brand-level sales increase of 33.86% year over year and a 9.26% increase in average price to $14.16, Edible performance in California sat at rank 20, implying a portfolio that is growing overall while its largest category is losing momentum and ceding mix to higher-priced form factors.
The shift toward Capsules and steady Vapor Pens signals a repositioning toward higher average selling prices (Capsules at $22.03 and Vapor Pens at $23.08) and away from price-sensitive Edibles (avg $11.41), with mix now concentrated 39.78% in non-Edible formats and growing month over month by 4.49% and 7.09%, respectively. Holding rank 20 in Edibles while Edible share contracts by 18.71% month over month, alongside a 2,281.68% year-over-year expansion in Capsules, implies Dr. Norm's is moving from Edible-led scale to a more margin-accretive, multi-format stance that can support price elevation while sacrificing some category-specific rank in the largest segment.
Competitive Landscape
Dr. Norm's sits at rank #20 in CA Edible for June 2026, down 4 positions year over year from #16 while slipping 3 spots from March 2026’s #17, against a category where Wyld held #1 with a -1.9% YoY sales change and Good Tide stayed #5 with a +28.5% YoY increase. The brand’s peak at #14 in January 2025 contrasts with a flat top tier where Kanha / Sunderstorm remained #3 with +10.9% YoY sales and Camino maintained #2 with +12.9% YoY growth, indicating that Dr. Norm's decline in rank comes amid competitors consolidating share through mid-teens to high-20s growth. The pattern implies a drift from mid-pack toward the lower top-20 unless mix or velocity shifts counter peers’ double-digit gains.
Notable Products
Indica Max Tablets 20-Pack (1000mg) led the movement in June 2026 with a steep -68.7% month-over-month drop while still holding rank 1, a combination that signals demand concentration in a flagship despite sharp contraction. Sleep Well - THC/CBN 2:1 Elderberry Nano Sleep Gummies 10-Pack (100mg THC, 50mg CBN) fell -20.5% to rank 2 as Fruity Pebbles Rice Crispy Bar (100mg) declined -31.4% at rank 3, and five of the top ten are Edible SKUs, indicating category share is broad but momentum-negative at the top. In contrast, Sativa Max Tablets 20-Pack (1000mg) in rank 6 grew +8.2% while the only sizable gainer among Edibles, Matcha Crispy Rice Bar (100mg), rose +42.1% at rank 8, implying product-level volatility within a largely down-trending edible set. This mix—one collapsing leader still at rank 1 and modest gains in a secondary capsule SKU against multiple double-digit edible declines—implies Dr. Norm's is pivoting toward higher-potency capsules as a stabilizing core while pruning or reformulating slower edible formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
